Home Stock

Stock Research: Fisher & Paykel Healthcare

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Fisher & Paykel Healthcare

NZC:FPH NZFAPE0001S2
73
  • Value
    6
  • Growth
    94
  • Safety
    Safety
    61
  • Combined
    60
  • Sentiment
    83
  • 360° View
    360° View
    73
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Fisher & Paykel Healthcare Corporation Limited designs, manufactures, and markets products and systems for use in acute and chronic respiratory care, surgery, and the treatment of obstructive sleep apnea. The company operates in the medical device industry, with products for hospital and homecare settings. It sells its products in over 120 countries worldwide, including Canada, the United States of America, Mexico, Costa Rica, the United Kingdom, Switzerland, and India. In the last fiscal year, the company had a market cap of $12,544 million, profits of $722 million, revenue of $1,148 million, and 7506 employees.

more

ANALYSIS: With an Obermatt 360° View of 73 (better than 73% compared with alternatives), overall professional sentiment and financial characteristics for the stock Fisher & Paykel Healthcare are above average. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for Fisher & Paykel Healthcare. The consolidated Growth Rank has a good rank of 94, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. This means that growth is higher than for 94% of competitors in the same industry. The consolidated Safety Rank at 61 means that the company has a financing structure that is safer than 61% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a good rank of 83, which means that professional investors are more optimistic about the stock than for 83% of alternative investment opportunities. But the consolidated Value Rank is less desirable at 6, meaning that the share price of Fisher & Paykel Healthcare is on the higher side compared with indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 94% of alternative stocks in the same industry. ...read more

more
Strongest Rank Price vs. Book (P/B)
Weakest Rank Profit Growth
Country New Zealand
Industry Health Care Equipment
Size Large
Website fphcare.com
Index
ASX 100
ASX 200
ASX 300
NZSX 50
Fisher & Paykel Healthcare stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Mar-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
6 13 26 19
Growth
94 99 49 33
Safety
Safety
61 75 73 59
Sentiment
83 46 58 37
360° View
360° View
73 78 59 21
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
27 7 3 19
Opinions Change
87 54 83 50
Pro Holdings
n/a 41 59 40
Market Pulse
47 83 83 69
Sentiment
83 46 58 37
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
6 13 26 19
Growth
94 99 49 33
Safety Safety
61 75 73 59
Combined
60 79 60 34
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
7 3 7 13
Price vs. Earnings (P/E)
10 11 14 19
Price vs. Book (P/B)
4 7 7 9
Dividend Yield
59 44 55 45
Value
6 13 26 19
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
64 77 78 10
Profit Growth
96 70 45 10
Capital Growth
94 98 19 95
Stock Returns
55 91 51 51
Growth
94 99 49 33
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
82 67 77 72
Refinancing
12 22 20 24
Liquidity
79 100 84 83
Safety Safety
61 75 73 59

Similar Stocks

Discover high‑ranked alternatives to Fisher & Paykel Healthcare and broaden your portfolio horizons.

Daiwa House

TYO:1925
Country: Japan
Industry: Electric Utilities
Size: XX-Large
Full Stock Analysis

Kinden

TYO:1944
Country: Japan
Industry: Construction & Engineering
Size: X-Large
Full Stock Analysis

Shionogi

TYO:4507
Country: Japan
Industry: Pharmaceuticals
Size: X-Large
Full Stock Analysis

CK Asset Holdings

HKG:1113
Country: Hong Kong
Industry: Real Estate Development
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This stock offers a high growth opportunity with safe financing and positive sentiment. It is typically expensive (low Value Rank), as investors pay a premium for high performance. It is for growth-focused investors comfortable paying a premium for a stock with strong future momentum.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews